11758572

Source:http://linkedlifedata.com/resource/pubmed/id/11758572

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0814812, umls-concept:C0872152, umls-concept:C1522240, umls-concept:C1551336
pubmed:issue	2
pubmed:dateCreated	2001-12-6
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9215384
pubmed:citationSubset	T
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Drugs, Generic
pubmed:status	MEDLINE
pubmed:issn	1064-590X
pubmed:author	pubmed-author:MossinghoffG JGJ
pubmed:issnType	Print
pubmed:volume	54
pubmed:owner	HSR
pubmed:authorsComplete	Y
pubmed:pagination	187-94
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11758572-Drug Design, pubmed-meshheading:11758572-Drug Industry, pubmed-meshheading:11758572-Drugs, Generic, pubmed-meshheading:11758572-History, 20th Century, pubmed-meshheading:11758572-Humans, pubmed-meshheading:11758572-Legislation, Drug, pubmed-meshheading:11758572-Patents as Topic, pubmed-meshheading:11758572-United States
pubmed:year	1999
pubmed:articleTitle	Overview of the Hatch-Waxman Act and its impact on the drug development process.
pubmed:affiliation	Oblon, Spivak, McClelland, Maier & Neustadt, P.C., Arlington, VA, USA
pubmed:publicationType	Journal Article, Historical Article